NCT07762690

Brief Summary

To investigate the effectiveness of mechanism-based cervical sensorimotor rehabilitation on cervical muscle activation, cervical proprioception, and migraine burden.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Aug 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Aug 2026Mar 2027

First Submitted

Initial submission to the registry

July 25, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

August 13, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 25, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

Cervical Sensorimotor RehabilitationJoint Position ErrorCervical Muscle ActivationEMG

Outcome Measures

Primary Outcomes (1)

  • cervical joint position error

    Cervical Joint Position Error (JPE) will be assessed to evaluate cervical proprioception using the Head Repositioning Accuracy Test. A lightweight laser pointer will be securely attached to the participant's head using an adjustable headband. Participants will be seated comfortably at a distance of 90 cm from a target grid mounted on a wall at eye level. At the beginning of each trial, participants will be instructed to identify and memorise their neutral head position while visually focusing on the centre of the target. They will then close their eyes and actively move their head to the end range of the required movement (flexion, extension, right rotation, left rotation, right lateral flexion, or left lateral flexion, depending on the testing protocol) before attempting to return to the original neutral position without visual feedback.The distance between the original target position and the repositioned laser point will be recorded and converted into angular error (degrees). Thre

    after the 8-week intervention, and at the 3-month follow-up

Secondary Outcomes (2)

  • Headache Impact Test (HIT-6)

    after the 8-week intervention (Week 8), and at the 3-month follow-up

  • Surface electromyographic (sEMG)

    baseline of 8-week intervention, and at the 3-month follow-up

Study Arms (2)

expermintal

EXPERIMENTAL

he experimental group will receive an eight-week mechanism-based cervical sensorimotor rehabilitation programme consisting of deep cervical flexor training, cervical motor control exercises, laser-guided cervical joint position error retraining, eye-head coordination exercises, scapular neuromuscular stabilization exercises, and a structured home exercise programme. Treatment will be delivered three sessions per week, with each session lasting approximately 40 minutes.

Other: cervical sensorimotor rehabilitationOther: conventional physiotherapy programme

control group

ACTIVE COMPARATOR

The control group will receive conventional physiotherapy, including cervical range of motion exercises, stretching exercises, postural education, and a home exercise programme, with the same treatment frequency and duration as the experimental group.

Other: conventional physiotherapy programme

Interventions

he experimental group will receive an eight-week mechanism-based cervical sensorimotor rehabilitation programme consisting of deep cervical flexor training, cervical motor control exercises, laser-guided cervical joint position error retraining, eye-head coordination exercises, scapular neuromuscular stabilization exercises, and a structured home exercise programme. Treatment will be delivered three sessions per week, with each session lasting approximately 40 minutes.

expermintal

Describe the conventional physiotherapy programme in the same level of detail as the experimental intervention, including exercise dosage, repetitions, duration, progression, and home programme.

control groupexpermintal

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female adults aged 18-55 years. Diagnosed with chronic migraine according to the International Classification of Headache Disorders, Third Edition (ICHD-3), defined as headache occurring on ≥15 days per month for more than 3 months, with migraine features present on at least 8 days per month.
  • History of migraine for at least 12 months prior to enrolment. Experiencing chronic migraine during the previous three months, confirmed through clinical history and/or headache diary.
  • Presence of cervical sensorimotor impairment, demonstrated by at least one of the following:
  • Increased cervical joint position error. Reduced cervical range of motion. Impaired cervical motor control. Neck pain or cervical dysfunction associated with migraine.

You may not qualify if:

  • Diagnosis of headache disorders other than chronic migraine (e.g., cervicogenic headache, cluster headache, or medication-overuse headache).
  • Previous cervical spine surgery, fracture, or significant cervical trauma. Cervical radiculopathy, myelopathy, or severe cervical spine pathology. Neurological disorders other than migraine (e.g., stroke, multiple sclerosis, Parkinson's disease).
  • Vestibular disorders affecting balance or proprioception. Inflammatory or systemic musculoskeletal diseases (e.g., rheumatoid arthritis, ankylosing spondylitis).
  • Pregnancy or breastfeeding. Physiotherapy, chiropractic treatment, acupuncture, or cervical rehabilitation within the previous 3 months.
  • Botulinum toxin injections or cervical pain interventions within the previous 3-4 months.
  • Changes in migraine preventive medication within the previous 4 weeks. Skin conditions preventing surface EMG electrode placement. Inability to comply with the study protocol or provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • mohamed naeem

    BeniSuef

    STUDY CHAIR

Central Study Contacts

mohamed naeem, assistant professor

CONTACT

mohmoud hamada, assistant professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This is a parallel group randomized controlled trial with two arms receiving different interventions
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Following baseline assessment, participants will be randomly assigned in a 1:1 ratio to either the expermential group or control group. An independent researcher will use a machine-generated random order to ensure a random distribution
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor, Basic science department, faculty of physical therapy, Beni Suef university

Study Record Dates

First Submitted

July 25, 2026

First Posted

August 13, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

August 13, 2026

Record last verified: 2026-07